RSS   Newsletter   Contact   Advertise with us
Post Online Media

Cellnovo appoints Rémi Soula as non-executive director

Rémi SoulaCellnovo Group, a medical technology company, announces the appointment of Rémi Soula as a non-executive director.
Article continues below

READ MORE Hill & Smith Holdings appoints Mark Reckitt as director

Mr. Soula has extensive experience in the French medical technology and biotechnology sector and is one of the three founders of Adocia, a clinical-stage biotechnology company.

Mr. Soula is currently the Director of Business Development and Intellectual Property Director at Adocia and has co-authored more than 30 patents and six scientific publications.

Prior to this, he spent three years at Flamel Technologies as Senior Chemist in Polymer Synthesis.

Mr. Soula holds a PhD in Polymer Science, a Post-doctorate from the Max Planck Institute in Potsdam and an MBA from HEC Paris.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy